Bojan Vujkovac

1.9k total citations
42 papers, 772 citations indexed

About

Bojan Vujkovac is a scholar working on Physiology, Organic Chemistry and Nephrology. According to data from OpenAlex, Bojan Vujkovac has authored 42 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Physiology, 8 papers in Organic Chemistry and 8 papers in Nephrology. Recurrent topics in Bojan Vujkovac's work include Lysosomal Storage Disorders Research (28 papers), Dialysis and Renal Disease Management (8 papers) and Carbohydrate Chemistry and Synthesis (8 papers). Bojan Vujkovac is often cited by papers focused on Lysosomal Storage Disorders Research (28 papers), Dialysis and Renal Disease Management (8 papers) and Carbohydrate Chemistry and Synthesis (8 papers). Bojan Vujkovac collaborates with scholars based in Slovenia, United States and Spain. Bojan Vujkovac's co-authors include Mišo Šabović, Alberto Ortíz, Dominique P. Germain, Renzo Mignani, Christoph Wanner, David G. Warnock, João Paulo Oliveira, Stephen Waldek, Gabor E. Linthorst and Bruno Cianciaruso and has published in prestigious journals such as American Journal of Kidney Diseases, Thrombosis and Haemostasis and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Bojan Vujkovac

39 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bojan Vujkovac Slovenia 15 602 247 193 179 144 42 772
Sima Canaan–Kühl Germany 15 398 0.7× 188 0.8× 110 0.6× 131 0.7× 110 0.8× 29 690
Bianca Visciano Italy 10 233 0.4× 115 0.5× 70 0.4× 74 0.4× 79 0.5× 19 439
Debora Karetová Czechia 12 492 0.8× 325 1.3× 140 0.7× 81 0.5× 176 1.2× 41 696
Shanat Baig United Kingdom 16 374 0.6× 242 1.0× 58 0.3× 36 0.2× 127 0.9× 38 745
Michiya Masue Japan 13 287 0.5× 211 0.9× 91 0.5× 125 0.7× 47 0.3× 20 520
Jana Reiterová Czechia 16 129 0.2× 43 0.2× 84 0.4× 20 0.1× 28 0.2× 53 663
Mai Ohsawa Japan 9 76 0.1× 41 0.2× 24 0.1× 31 0.2× 35 0.2× 14 381
Havva Yazıcı Türkiye 9 36 0.1× 55 0.2× 153 0.8× 21 0.1× 32 0.2× 48 527
Ishikazu Mizuno Japan 11 103 0.2× 139 0.6× 33 0.2× 3 0.0× 13 0.1× 33 506
Motasem Melhem Kuwait 14 132 0.2× 109 0.4× 30 0.2× 2 0.0× 38 0.3× 32 531

Countries citing papers authored by Bojan Vujkovac

Since Specialization
Citations

This map shows the geographic impact of Bojan Vujkovac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bojan Vujkovac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bojan Vujkovac more than expected).

Fields of papers citing papers by Bojan Vujkovac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bojan Vujkovac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bojan Vujkovac. The network helps show where Bojan Vujkovac may publish in the future.

Co-authorship network of co-authors of Bojan Vujkovac

This figure shows the co-authorship network connecting the top 25 collaborators of Bojan Vujkovac. A scholar is included among the top collaborators of Bojan Vujkovac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bojan Vujkovac. Bojan Vujkovac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vujkovac, Bojan, João Paulo Oliveira, Gabriela Dostálová, et al.. (2025). Identification of genetic variants associated with Fabry nephropathy progression using whole-exome sequencing. Molecular Genetics and Metabolism. 145(4). 109191–109191.
2.
Vujkovac, Bojan, et al.. (2025). Telomere Length, Oxidative Stress, and Kidney Damage Biomarkers in Fabry Nephropathy. Cells. 14(3). 218–218. 1 indexed citations
3.
Vujkovac, Bojan, et al.. (2023). Urinary-derived extracellular vesicles reveal a distinct microRNA signature associated with the development and progression of Fabry nephropathy. Frontiers in Medicine. 10. 1143905–1143905. 10 indexed citations
4.
Linhart, Aleš, Gabriela Dostálová, Kathy Nicholls, et al.. (2023). Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study. Orphanet Journal of Rare Diseases. 18(1). 332–332. 24 indexed citations
5.
Germain, Dominique P., Gheona Altarescu, Roberto Barriales‐Villa, et al.. (2022). An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease. Molecular Genetics and Metabolism. 137(1-2). 49–61. 60 indexed citations
6.
Hughes, Derralynn, Olivier Lidove, Kathy Nicholls, et al.. (2022). Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?. Orphanet Journal of Rare Diseases. 17(1). 42–42. 7 indexed citations
7.
Vujkovac, Bojan, et al.. (2021). Podocyturia in Fabry disease: a 10-year follow-up. Clinical Kidney Journal. 15(2). 269–277. 7 indexed citations
8.
Wanner, Christoph, Ulla Feldt‐Rasmussen, Ana Jovanović, et al.. (2020). Cardiomyopathy and Kidney Function in Agalsidase Beta-Treated Female Fabry Patients: A Pre-Treatment vs. Post-Treatment Analysis. ESC Heart Failure. 7(3). 825–834. 21 indexed citations
9.
Vujkovac, Andreja Cokan, et al.. (2019). Aging in Fabry Disease: Role of Telomere Length, Telomerase Activity, and Kidney Disease. ˜The œNephron journals/Nephron journals. 144(1). 5–13. 14 indexed citations
10.
Vujasinović, Miroslav, et al.. (2015). Exocrine pancreatic insufficiency is not a cause of abdominal complaints in patients with Fabry disease. Wiener klinische Wochenschrift. 127(23-24). 931–934. 1 indexed citations
11.
Warnock, David G., Christie P. Thomas, Bojan Vujkovac, et al.. (2015). Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy. Journal of Medical Genetics. 52(12). 860–866. 48 indexed citations
12.
Warnock, David G., Alberto Ortíz, Michael Mauer, et al.. (2011). Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation. Nephrology Dialysis Transplantation. 27(3). 1042–1049. 123 indexed citations
13.
Paschke, Eduard, Günter Fauler, Axel Schlagenhauf, et al.. (2010). Urinary Total Globotriaosylceramide and Isoforms to Identify Women With Fabry Disease: A Diagnostic Test Study. American Journal of Kidney Diseases. 57(5). 673–681. 15 indexed citations
14.
Vujkovac, Bojan, et al.. (2006). Recommendation for diagnosis and treatment of fabry’s disease in Slovenia. Slovenian Medical Journal. 75(12). 1 indexed citations
15.
Šabović, Mišo, Barbara Salobir, Jadranka Buturović‐Ponikvar, et al.. (2005). The study of anaemia-related haemostasis impairment in haemodialysis patients by in vitro closure time test. Thrombosis and Haemostasis. 93(2). 375–379. 7 indexed citations
16.
Pajek, Jernej, Maja Pajek, Sebastjan Bevc, et al.. (2005). Epoetin Responsiveness in Peritoneal Dialysis Patients: A Multi‐center Slovenian Study. Therapeutic Apheresis and Dialysis. 9(3). 228–232. 6 indexed citations
17.
Vujkovac, Bojan, et al.. (2004). Remarkable variability in renal disease in a large Slovenian family with Fabry disease. European Journal of Human Genetics. 12(8). 678–681. 28 indexed citations
18.
Šabović, Mišo, et al.. (2003). Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients. Nephrology Dialysis Transplantation. 18(7). 1388–1391. 31 indexed citations
19.
Vujkovac, Bojan, et al.. (2002). USE OF SILDENAFIL (VIAGRA®) FOR ERECTILE DYSFUNCTION IN DIALYSIS PATIENTS – OUR FIRST EXPERIENCE. Slovenian Medical Journal. 71(1).
20.
Vujkovac, Bojan, et al.. (1998). Successful treatment of bleeding from colonic angiodysplasias with tranexamic acid in a hemodialysis patient. American Journal of Kidney Diseases. 31(3). 536–538. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sima Canaan–Kühl Breakdown of academic impact, for papers by Bianca Visciano Breakdown of academic impact, for papers by Debora Karetová Breakdown of academic impact, for papers by Shanat Baig Breakdown of academic impact, for papers by Michiya Masue Breakdown of academic impact, for papers by Jana Reiterová Breakdown of academic impact, for papers by Mai Ohsawa Breakdown of academic impact, for papers by Havva Yazıcı Breakdown of academic impact, for papers by Ishikazu Mizuno Breakdown of academic impact, for papers by Motasem Melhem
Rankless by CCL
2026